Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton

Kiểm soát axit dạ dày bằng hóa học chọn lọc đồng phân quang học

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Tổng quan

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Quy trình hóa học

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Nguyên liệu thô

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Sản phẩm cuối

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Lưu ý an toàn

Đổi mới gần đây

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Quy mô sản xuất

800

tấn/năm

$3.5 billion

giá trị thị trường

Xem thêm Pharmaceutical & Drug Manufacturing

Sản Xuất Bán Tổng Hợp Amoxicillin

Global Industrial Scale

Sản Xuất Insulin Người Tái Tổ Hợp

Global Industrial Scale

Sản Xuất Penicillin G bằng Lên Men

Global Industrial Scale

Tổng Hợp Aspirin bằng Axetyl Hóa Axit Salixylic

Global Industrial Scale

Tổng Hợp Ibuprofen — Quy Trình Xanh BHC

Global Industrial Scale

Tổng Hợp Metformin Hydrochloride

Global Industrial Scale

Tổng Hợp Paracetamol (Acetaminophen)

Global Industrial Scale

Frequently Asked Questions

What industry uses Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton?
Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton?
Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Tổng Hợp Omeprazole cho Thuốc Ức Chế Bơm Proton?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).